Sort
11,323 grants matching “glioblastoma”
Pharmacology of Targeted Therapy to Brain Tumors
$363,454Francis C Szoka · University Of California, San Francisco · R01 · FY2007 · CA
Characterization of FGFR4 mutations in Rhabdomyosarcoma
$363,432Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Quantitative Analysis of Epidermal Growth Factor Receptor Signaling Networks
$363,410Forest M White · Massachusetts Institute Of Technology · R01 · FY2008 · CA
Project 2: Dissection of clonal architecture and evolution in solid tumors
$363,341Antonio Iavarone · Columbia University Health Sciences · U54 · FY2019 · CA
Transcriptional control of OPC fate specification and homing to gray matter and white matter in the CNS
$363,329Tou Yia Vue · University Of New Mexico Health Scis Ctr · R01 · FY2024 · NS
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
$363,164Juan Fueyo · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
$363,164Juan Fueyo · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Reprogramming the Tumor Microenvironment to Improve Immunotherapy of Glioblastoma by Co-Targeting VEGF and Ang2
$363,077Dai Fukumura · Massachusetts General Hospital · R01 · FY2025 · NS
Project 2: Overcoming drug-induced resistance to intrinsic apoptosis in glioblastoma
$363,074David A. Nathanson · University Of California Los Angeles · P50 · FY2022 · CA
Identification and targeting of mechanisms specific to glioma stem cells in glioblastoma
$362,964Daniel J Brat · Northwestern University At Chicago · R01 · FY2021 · CA
Crosstalk between glioma cells & immune cells in the tumor microenvironment: Ther
$362,892Maria G Castro · University Of Michigan At Ann Arbor · R01 · FY2013 · NS
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
$362,840Michael J Eck · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Targeting oncogenic epigenetic mechanisms in IDHmut/ATRXloss Astrocytoma
$362,823Yunqing Li · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2024 · NS
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells
$362,569Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · CA
Targeting Brain Tumor Stem Cells In The Hypoxic Microenvironment
$362,569Eli E Bar · Case Western Reserve University · R01 · FY2018 · CA
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells
$362,569Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · CA
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells
$362,569Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2018 · CA
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells
$362,569Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · CA
Polyamine Catabolism and Therapeutic Resistance in Glioblastoma Multiforme
$362,569Scott Michael Welford · Case Western Reserve University · R01 · FY2015 · CA
Targeting Brain Tumor Stem Cells In The Hypoxic Microenvironment
$362,569Eli E Bar · Case Western Reserve University · R01 · FY2015 · CA
Targeting Brain Tumor Stem Cells In The Hypoxic Microenvironment
$362,569Eli E Bar · Case Western Reserve University · R01 · FY2016 · CA
Biochemistry of Brain Tumor Microvessel Development
$362,561John J Laterra · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2007 · NS
Optimization of GMAK to treat glioblastoma multiforme
$362,512David E Weinstein · Gliamed, Inc. · R43 · FY2006 · NS
Project 2: Sparing in Tumor Free Animals
$362,497Charles Limoli · University Of California-Irvine · P01 · FY2020 · CA
Project 1: Optimizing Treatment of GBM by FLASH
$362,497Charles Limoli · University Of California-Irvine · P01 · FY2020 · CA